Obsessive Compulsive Disorder
Conditions
Keywords
Obsessive Compulsive Disorder, Transcranial Magnetic Stimulation, Treatment
Brief summary
This study aimed at verifying whether sessions of repetitive transcranial magnetic stimulation over a certain brain area (the supplementary motor area) could be useful in the relief of Obsessive-Compulsive Disorder symptoms.
Detailed description
Patients were randomly administered either real (n = 12) or sham (n = 10) rTMS, once a day, 5 days a week, for 2 weeks. Randomization was performed according to a computer-generated schedule. Subjects and scale-rater physician were blind to treatment status of individuals. Only the rTMS administrator was aware of group allocations. Treatment response was assessed by self-and clinician-rated scales before treatment, immediately after treatment and 3 months thereafter, with the same examiner following a subject throughout the study. All patients included in the study had failed adequate pharmacological treatment for at least 2 antiobsessional drugs. Their prescription drugs were continued without change in dosage regimens throughout the study.
Interventions
rTMS was administered by means of a NEURO-MS (NEUROSOFT LTD®, Russia) with a focal 8-shaped 70 mm coil. Stimulation parameters were 1-Hz, 20-min trains (1200 pulses/day) at 100% of resting MT, once a day, 5 days a week, for 2 weeks.
The sham treatment was performed using the Neurosoft ® sham coil. A metal plate placed inside this coil prevents the magnetic field from stimulating the cortex. This coil looks and sounds like an active coil.
Sponsors
Study design
Eligibility
Inclusion criteria
* age 18 to 60 years * diagnosis of obsessive-compulsive disorder (OCD) according to DSM-IV-TR criteria and having OCD of at least moderate severity (YBOCS score of 16 or above).
Exclusion criteria
* subjects with comorbid psychiatric disorders (except depression - HAM-D ) or history of drug abuse * significant head injury, or of any neurosurgical procedure * pregnant women * patients with metal implants or illnesses that prevent attendance to sessions * patients with a history of seizure or bearing pacemakers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Y-BOCS scale scores relative to baseline | assessments were at baseline, at 2 weeks and at 3 months | Y-BOCS: Yale-Brown Obsessive-Compulsive Scale |
Countries
Brazil